Fox Chase | Strategic Alliance Partners

Molecular testing helps distinguish kidney cancer subtypes, ensuring patients get accurate diagnoses and treatment plans, avoiding unnecessary surgery.

Obtaining an accurate diagnosis is a crucial first step in kidney cancer care, according to Dr. Shuanzeng “Sam” Wei of Fox Chase Cancer Center.

Dr. Susan Rux, a respected nursing leader and researcher, empowers teams, mentors future leaders, and advances inclusive clinical research in kidney cancer.

Patients with relapsed or refractory multiple myeloma should consider quality of life with survival when choosing the most suitable treatment option.